The tablet Barif contains Febuxostat and is made by Square Pharmaceuticals Ltd. It is not intended for the treatment of asymptomatic hyperuricemia (high uric acid without symptoms).
There are 18 brands of Febuxostat listed in Bangladesh. 6 of them have a lower unit price than Barif. The lowest listed price is Fostat 80 mg Tablet at ৳ 10.00 per unit.
What is Barif 80 mg Tablet?
Barif is a tablet from Square Pharmaceuticals Ltd., with the generic name Febuxostat. Febuxostat is a non-purine, selective xanthine oxidase inhibitor. It works by blocking xanthine oxidase, the enzyme responsible for making uric acid, and so lowers the level of uric acid in the blood. Your doctor will decide whether it is suitable for you and how long you should take it.
Uses of Barif
It is not intended for the treatment of asymptomatic hyperuricemia (high uric acid without symptoms). Barif 80 mg tablet is used for the chronic management of hyperuricemia in patients with gout. Ask the doctor or pharmacist if you are unsure why it has been prescribed for you. The doctor decides whether this medicine is suitable.
How to use Barif
Barif is a tablet taken by mouth. Swallow the tablet with water. Take Barif 80 mg tablet exactly as your doctor tells you. If you miss a dose or are unsure about timing, ask the doctor or pharmacist for guidance. Do not change the dose or stop early without asking your doctor.
Side effects of Barif
The most common ones reported include liver function abnormalities, nausea, joint pain (arthralgia) and rash. Your doctor may monitor your liver function during treatment. Some people may notice side effects while taking Febuxostat. Do not stop or change the medicine on your own. Contact your doctor if you notice anything unusual after taking it.
Safety and precautions
Gout flares may occur when treatment begins; the doctor may suggest preventive therapy. Do not take Barif 80 mg tablet if you are being treated with azathioprine, mercaptopurine or theophylline. It may interact with these and other medicines. Keep out of reach of children.
Frequently asked questions
Why is Barif prescribed?
It is not intended for the treatment of asymptomatic hyperuricemia (high uric acid without symptoms). Barif 80 mg tablet is used for the chronic management of hyperuricemia in patients with gout.
How do I use Barif correctly?
Barif is a tablet taken by mouth. Swallow the tablet with water.
What are the side effects of Barif?
The most common ones reported include liver function abnormalities, nausea, joint pain (arthralgia) and rash. Your doctor may monitor your liver function during treatment.
Febuxostat is indicated for the chronic management of hyperuricemia in patients with gout. Febuxostat is not recommended for the treatment of asymptomatic hyperuricemia.
Pharmacology
Febuxostat is a non-purine, selective xanthine oxidase (XO) inhibitor. It decreases serum uric acid level by inhibiting xanthine oxidase, which is responsible for uric acid production. Xanthine oxidase breaks down hypoxanthine to xanthine and thus to uric acid. Febuxostat is not expected to inhibit other enzymes involved in purine and pyrimidine synthesis and metabolism at therapeutic concentrations.
Dosage & Administration
Febuxostat is recommended at 40 mg or 80 mg once daily. The recommended starting dose of Febuxostat is 40 mg once daily. For patients who do not achieve a serum uric acid less than 6 mg /dL after 2 weeks with 40 mg, Febuxostat 80 mg is recommended. Febuxostat can be administered without regard to food or antacid use. No dose adjustment is necessary when administering Febuxostat to patients with mild to moderate renal or hepatic impairment.
Interaction
Concomitant administration of Febuxostat with azathioprine, mercaptopurine or theophylline could increase plasma concentrations of these drugs resulting in severe toxicity.
Contraindications
Febuxostat is contraindicated in patients being treated with azathioprine, mercaptopurine, or theophylline.
Side Effects
The most common adverse events associated with the use of Febuxostat may include liver function abnormalities, nausea, arthralgia, and rash.
Pregnancy & Lactation
Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. Febuxostat should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is not known whether this drug is excreted in human milk. Caution should be exercised when Febuxostat is administered to a nursing woman.
Precautions & Warnings
Gout Flare: An increase in gout flares is frequently observed during initiation of anti-hyperuricemic agents, including Febuxostat. If a gout flare occurs during treatment, Febuxostat need not be discontinued. Prophylactic therapy (i.e., non-steroidal anti-inflammatory drug (NSAID) or colchicine upon initiation of treatment) may be beneficial for up to six months.
Cardiovascular Events: A higher rate of cardiovascular thromboembolic events was observed in patients treated with febuxostat than allopurinol in clinical trials. Monitor for signs and symptoms of MI and stroke.
Liver Enzyme Elevation: Transaminase elevations have been observed in febuxostat -treated patients. Monitor liver function tests periodically.
Overdose Effects
Febustat was studied in healthy subjects in doses up to 300 mg daily for seven days without evidence of dose-limiting toxicities.
Storage Conditions
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.
Alternative brands of Febuxostat
Other brands with the same generic name, cheapest first.